Research ethics. The complexities of genomic identifiability.
Laura L Rodriguez, Lisa D Brooks, Judith H Greenberg...
https://pubmed.ncbi.nlm.nih.gov/23329035/Actively Recruiting
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-04-14
1000
Participants Needed
13
Research Sites
N/A
Total Duration
Researchers are studying acute kidney injury AKI and chronic kidney disease CKD, which are major global health issues with limited treatment options. This observational trial aims to improve understanding of these conditions by analyzing kidney biopsies and related clinical data to identify different disease types and potential targets for new treatments. The study involves collaboration among multiple centers focusing on collecting and interpreting detailed molecular and clinical information. Participants will undergo kidney biopsies to obtain tissue samples for molecular analysis, alongside other evaluations such as MRI scans and retina exams. The study includes groups with acute intrinsic kidney disease, diabetic kidney disease, hypertension-associated CKD, and type 1 diabetes with or without kidney involvement. Advanced techniques will be used to create a kidney tissue atlas and link findings to clinical features. During the study, participants will provide biospecimens like urine, blood, stool, and DNA at baseline and follow-up visits, which may be in person or remote. Their clinical records will also be reviewed periodically. Researchers will monitor biopsy-related outcomes up to six months and track kidney disease progression for up to ten years. Safety and participant well-being are prioritized throughout the study.
CONDITIONS
Kidney Precision Medicine Project
A
Ashveena Dighe, MS, MPH
K
Kristina Blank, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) to assess eligibility and provide informed consent
Duration - Up to 8 weeks around biopsy
Participants undergo a kidney biopsy and other diagnostic procedures to collect kidney tissue and imaging data for molecular and clinical analysis.
1 kidney biopsy procedure visit and 1 retina scan visit occurring up to 6 weeks before or 8 weeks after biopsy; 1 MRI visit
Duration - Up to 10 years
Participants are followed through scheduled in-person and remote visits, along with periodic review of clinical data and biospecimens, to monitor kidney disease progression.
Scheduled in-person and remote study visits with periodic electronic health record reviews
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Laura L Rodriguez, Lisa D Brooks, Judith H Greenberg...
https://pubmed.ncbi.nlm.nih.gov/23329035/Steven G Coca, Swathi Singanamala, Chirag R Parikh
https://pubmed.ncbi.nlm.nih.gov/22113526/David Collister, Neesh Pannu, Feng Ye...
https://pubmed.ncbi.nlm.nih.gov/29051143/Jennifer A Schaub, Rajasree Menon, Ricardo Melo Ferreira...
https://pubmed.ncbi.nlm.nih.gov/42579799/Keith C Norris, Sandra F Williams, Connie M Rhee...
https://pubmed.ncbi.nlm.nih.gov/28281281/John A Kellum, Florentina E Sileanu, Raghavan Murugan...
https://pubmed.ncbi.nlm.nih.gov/25568178/Kristin M Corapi, Joline L T Chen, Ethan M Balk...
https://pubmed.ncbi.nlm.nih.gov/22537423/John A Kellum, Rinaldo Bellomo, Claudio Ronco
https://pubmed.ncbi.nlm.nih.gov/22572776/Raghavan Murugan, Vijay Karajala-Subramanyam, Minjae Lee...
https://pubmed.ncbi.nlm.nih.gov/20032961/Florentina E Sileanu, Raghavan Murugan, Nicole Lucko...
https://pubmed.ncbi.nlm.nih.gov/25424992/Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor